Lanean...
CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma
Cancer cells commonly develop resistance to immunotherapy by loss of antigen expression. Combinatorial treatments that increase levels of the target antigen on the surface of cancer cells have the potential to restore efficacy to immunotherapy. Here, we use our CRISPR interference– and CRISPR activa...
Gorde:
Argitaratua izan da: | Blood Adv |
---|---|
Egile Nagusiak: | , , , , , , , , , , , , , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
American Society of Hematology
2020
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7362346/ https://ncbi.nlm.nih.gov/pubmed/32589729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019001346 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|